When it comes to TV ads, many consumers—and doctors—claim no one wants to see them. But the actual data show few people click away when the ads run. Data collected by realtime TV ad tracker iSpot.tv ...
New year, new leader on the pharma TV ad spending board. In January, Pfizer’s Xeljanz topped AbbVie's Humira in a rare bypass of the usual No. 1, spending more than $40 million on national TV time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results